CClinicalTrials.gg
Enrolling by invitationNCT07419503010Fit'RUpdated Feb 19, 2026

010Fit'R - Healthy Lifestyle Interventions for Children With Overweight

An interventional study of 010 Fit'R intervention in Overweight and Children, sponsored by Erasmus Medical Center. Enrolling by invitation at 1 site in Netherlands. Open to participants aged 4 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-19.

Sponsored by Erasmus Medical Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Not applicable
Ages
4 Years to 12 Years
Sex
All
01

Study summary

Overweight is a leading risk factor for non-communicable diseases. In the Netherlands, about 11% of children aged 4-12 years are overweight. The causes of childhood overweight are multifaceted, involving (epi)genetic, environmental, socioeconomic, and behavioral factors. The societal consequences are far-reaching, including lower academic performance, reduced quality of life and a greater risk of developing obesity in adulthood.

Lifestyle interventions with diet and physical activity components have been shown to effectively reduce childhood overweight. The "010 Fit'R - Rotterdam approach for children with overweight" targets children between 4 and 12 years old and their parents. The program consists of multicomponent interventions addressing various lifestyle aspects, such as physical activity, nutrition, motor skills and healthy behaviours aiming to foster sustainable lifestyle changes. Providers were invited by the municipality of Rotterdam to develop interventions within the policy framework of 010 Fit'R. 12 providers were selected by the municipality based on the selection criteria (quality of the program; experience with the activities and target group; demonstrable connection with the area; connection with the target group; recruitment strategy; costs) and distributed over different neighbourhoods. This study evaluates the healthy lifestyle interventions involved in 010 Fit'R in terms of effectiveness and implementation outcomes.

Quantitative data includes self-reported questionnaires, administrative data, a motor skill performance assessment and height and weight measurements to determine Body Mass Index (BMI). Data will be collected through self-reported questionnaires filled in by the parents of children who participate in 010 Fit'R. Additionally, children will be assessed on motor skills by providers of healthy lifestyle interventions involved in 010 Fit'R. Moreover, weight and height will be measured by the provider following standardized procedures. The parental questionnaire, motor skills and BMI will be assessed pre and post intervention. Administrative data includes data reported by providers on implementation outcomes, for example, data regarding enrolment and retention.

Qualitative data includes documentary evidence of each healthy lifestyle intervention involved in 010 Fit'R to assess 'effective components' of interventions. In addition, two workshops with providers and/or practitioners of interventions will be held to map the context, working elements and outcomes.

Focus groups (FGs) and semi-structured interviews are used to gather information from parents, children and providers and/or practitioners regarding implementation outcomes.

02

Conditions studied

  • Overweight
  • Children

Browse trials for

Keywords

  • overweight
  • children
  • lifestyle intervention
03

In context

Overweight

3,670 studies on the registry are indexed under Overweight; 849 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 73 across 3,175 interventional studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

Erasmus Medical Center is the lead sponsor of 466 studies on the registry; 179 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Providers of the interventions will recruite children (4-12 years old) with overweight to participate in their intervention. All children (and their parents) participating in the interventions are invited to participate in the evaluation research study.

Inclusion criteria

Inclusion Criteria:

  • Child participates in the 010Fit'R program and is between 4 and 12 years old (at the start of recruitment)
  • Parents of children participating in the 010 Fit'R program
  • Provider (e.g. participate in interview) is actively involved in promoting, implementing or conducting a healthy lifestyle intervention funded by 010Fit'R

All participants should be able to comprehend provided information to make an informed decision for participation and should provide consent for participating. In case of children the parent(s) consent, as well as the child when 12 years old.

Exclusion criteria

Exclusion Criteria:

  • Outside of the age range, no consent for participation from provider, parent and/or child
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1,000 participants (estimated)

Study arms

  • Experimental
    Lifestyle intervention

    Children (4-12 years old) participate in one of 12 healthy lifestyle interventions focused on physical activity, nutrition and additional lifestyle factors

    Behavioral: 010 Fit'R intervention

Interventions

  • Behavioral010 Fit'R intervention

    Within the policy framework of 010 Fit'R, 12 different healthy lifestyle interventions will be implemented for children with overweight. Children participate in one of the 12 interventions. All interventions consist of at least one physical activity each week and encouraging a healthy lifestyle in children, individually or in groups, and advising children and their parents on nutrition, exercise, motor skills, and sustainable behavioral change.

06

What researchers measure

Primary outcomes

  1. PROMIS - assessed by a questionnaire

    Health-related quality of life measured by the Patient-Reported Outcomes Measurement Information System

    Time frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)

Secondary outcomes

  1. BMI - assessed by physical measurement

    Based on height and weight

    Time frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)

  2. Motor skills - assessed by physical measurement

    4 S-en test (Kernebeek et al., 2018)

    Time frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)

  3. Nutrition - assessed by a questionnaire

    Frequency of eating breakfast, fruit, vegetables, whole grain producents, sweet beverages, snacks

    Time frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)

  4. Physical activity - assessed by a questionnaire

    Frequency and duration of playing sports, playing outside, perception of physical behaviour

    Time frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)

  5. Sleep behaviour - assessed by a questionnaire

    General duration of sleep (hours) and sleep behaviour in the past 2 months

    Time frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)

  6. Screen time - assessed by a questionnaire

    General duration of screen time (hours) on weekdays and during weekends

    Time frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)

Other outcomes

  1. Demographic variables - assessed by a questionnaire

    Age, gender, living situation, country of birth, income and education level of parents

    Time frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)

  2. Feasibility data on implementation outcomes

    Feasibility data on implementation outcomes (e.g. reach, adoption, implementation, sustainability) will be collected through questionnaires for parents, focus groups with children and parents, administrative data and interviews with providers

    Time frame: At the end of an intervention (depending on intervention at 12 to 40 weeks)

07

Study locations

1 site
  • Department of Public Health, Erasmus MC University Medical Center
    Rotterdam, South Holland 3015GD, Netherlands
08

References and documents

Individual participant data

Plan to share: Undecided — A data sharing statement will be finalized when known which percentage of participants consent for sharing data outside of our own organization.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07419503
Lead sponsor
Erasmus Medical Center
Responsible party
Wilma Jansen (Senior researcher, Erasmus Medical Center) — Principal investigator
First posted
Feb 19, 2026
Start date
Dec 11, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Feb 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion